Resiquimod Induces C-C Motif Chemokine Ligand 2 Via Nuclear Factor-Kappa B in SH-SY5Y Human Neuroblastoma Cells
NeuroMolecular Medicine · 2024
DOI: 10.1007/s12017-024-08782-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2024. Verfasst von Masatoshi Kaizuka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. Hauptthemen laut MEDLINE: Chemokine CCL2, Chemokine CXCL10, Imidazoles, Interleukin-8. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Toll-like receptor (TLR) 7 plays an important role in recognizing virus-derived nucleic acids. TLR7 signaling in astrocytes and microglia is critical for activating immune responses against neurotrophic viruses. Neurons express TLR7, similar to glial cells; however, the role of neuronal TLR7 has not yet been fully elucidated. This study sought to determine whether resiquimod, the TLR7/8 agonist, induces the expression of inflammatory chemokines in SH-SY5Y human neuroblastoma cells. Immunofluorescence microscopy revealed that TLR7 was constitutively expressed in SH-SY5Y cells. Stimulation with resiquimod induced C-C motif chemokine ligand 2 (CCL2) expression, accompanied by the activation of nuclear factor-kappa B (NF-κB) in SH-SY5Y cells. Resiquimod increased mRNA levels of C-X-C motif chemokine ligand 8 (CXCL8) and CXCL10, while the increase was slight at the protein level. Knockdown of NF-κB p65 eliminated resiquimod-induced CCL2 production. This study provides novel evidence that resiquimod has promising therapeutic potential against central nervous system viral infections through its immunostimulatory effects on neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
- Department of Vascular Biology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. kawaguchi.s@hirosaki-u.ac.jp.
- Department of Vascular Biology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
- Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
- Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Science, 5 Zaifu-cho, Hirosaki, Aomori, 036-8564, Japan.
Zitieren
APA
Kaizuka, M., Kawaguchi, S., Tatsuta, T., Tachizaki, M., Kobori, Y., Tanaka, Y., Seya, K., Matsumiya, T., Imaizumi, T., & Sakuraba, H. (2024). Resiquimod Induces C-C Motif Chemokine Ligand 2 Via Nuclear Factor-Kappa B in SH-SY5Y Human Neuroblastoma Cells. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-024-08782-5
Vancouver
Kaizuka M, Kawaguchi S, Tatsuta T, Tachizaki M, Kobori Y, Tanaka Y, et al. Resiquimod Induces C-C Motif Chemokine Ligand 2 Via Nuclear Factor-Kappa B in SH-SY5Y Human Neuroblastoma Cells. NeuroMolecular Medicine. 2024. doi:10.1007/s12017-024-08782-5
BibTeX
@article{Kaizuka2024,
author = {Kaizuka, Masatoshi and Kawaguchi, Shogo and Tatsuta, Tetsuya and Tachizaki, Mayuki and Kobori, Yuri and Tanaka, Yusuke and Seya, Kazuhiko and Matsumiya, Tomoh and Imaizumi, Tadaatsu and Sakuraba, Hirotake},
title = {Resiquimod Induces C-C Motif Chemokine Ligand 2 Via Nuclear Factor-Kappa B in SH-SY5Y Human Neuroblastoma Cells},
journal = {NeuroMolecular Medicine},
year = {2024},
doi = {10.1007/s12017-024-08782-5}
}
EUVIMED